Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hypercholesterolemia, familial combined"'
Autor:
Roopa Mehta, Arsenio Vargas-Vázquez, Neftali E. Antonio-Villa, Daniel Elías-López, Alexandro Martagón-Rosado, Fabiola Del Razo-Olvera, Gabriela A. Galán-Ramírez, Liliana Muñoz-Hernandez, Ivette Cruz-Bautista, Carlos A. Aguilar-Salinas
Publikováno v:
Revista Mexicana de Endocrinología, Metabolismo y Nutrición, Vol 11, Iss 2 (2024)
Background: Arterial stiffness [assessed with pulse wave velocity (PWV)] can predict atherosclerotic cardiovascular disease. Objective: To evaluate arterial stiffness in patients with familial hypercholesterolemia (FH) and familial combined hyperlipi
Externí odkaz:
https://doaj.org/article/c856b38c89f64f8c9a0a55b32bb8f0d6
Publikováno v:
Revista médica de Chile v.142 n.7 2014
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Statins are the preferred treatment for hypercholesterolemia and several studies have demonstrated their long-term safety and efficacy in reducing cardiovascular morbidity and mortality. However, in some cases of severe hypercholesterolemia such as h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef380cbb37fad84dc11f1d982df42baf
https://doi.org/10.4067/s0034-98872014000700008
https://doi.org/10.4067/s0034-98872014000700008
Publikováno v:
Revista médica de Chile, Volume: 142, Issue: 7, Pages: 880-888, Published: JUL 2014
Statins are the preferred treatment for hypercholesterolemia and several studies have demonstrated their long-term safety and efficacy in reducing cardiovascular morbidity and mortality. However, in some cases of severe hypercholesterolemia such as h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______614::c2c6f5244c2d738ea9045758874d7b11
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000700008&lng=en&tlng=en
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000700008&lng=en&tlng=en
Autor:
Arteaga Ll, Antonio, Cuevas M, Ada, Rigotti R, Attilio, González, Francisco, Castillo, Sergio, Mata L, Pedro, Alonso K, Rodrigo
Publikováno v:
Revista médica de Chile, Volume: 135, Issue: 2, Pages: 216-220, Published: FEB 2007
Heterozygous familial hypercholesterolemia affects one every 400 individuals, is caused by mutations in the LDL receptor gene and is associated with premature coronary artery disease. Nowadays, LDL cholesterol can be efficiently reduced with the new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______614::b97339d5c9d21014098ed255ae4712af
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000200011&lng=en&tlng=en
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000200011&lng=en&tlng=en
Autor:
Pedro Mata L, Francisco Javier Callejas Gonzalez, Rodrigo Alonso K, Ada Cuevas M, Attilio Rigotti R, Antonio Arteaga Ll, Sergio García Castillo
Publikováno v:
Revista médica de Chile v.135 n.2 2007
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Heterozygous familial hypercholesterolemia affects one every 400 individuals, is caused by mutations in the LDL receptor gene and is associated with premature coronary artery disease. Nowadays, LDL cholesterol can be efficiently reduced with the new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8d39501d8329017233d9ca71cba9b6
https://doi.org/10.4067/s0034-98872007000200011
https://doi.org/10.4067/s0034-98872007000200011
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.